Cargando…
Nitrous oxide and vitamin B12 in sickle cell disease: Not a laughing situation
Nitrous oxide (N(2)O) is widely used as an anesthetic or an analgesic. N(2)O prolonged and recurrent administration is known to affect vitamin B12 metabolism with subsequent clinical consequences. We report herein the case of a 13-year-old girl with sickle cell disease exhibiting severe neurological...
Autores principales: | Desprairies, Camille, Imbard, Apolline, Koehl, Bérengère, Lorrot, Mathie, Gaschignard, Jean, Sommet, Julie, Pichard, Samia, Holvoet, Laurent, Faye, Albert, Benkerrou, Malika, Benoist, Jean-François, Schiff, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078522/ https://www.ncbi.nlm.nih.gov/pubmed/32195121 http://dx.doi.org/10.1016/j.ymgmr.2020.100579 |
Ejemplares similares
-
Diagnostic contribution of metabolic workup for neonatal inherited metabolic disorders in the absence of expanded newborn screening
por: Bower, Alexandra, et al.
Publicado: (2019) -
Variability of Prognostic Results Based on Biological Parameters in Sickle Cell Disease Cohort Studies in Children: What Should Clinicians Know?
por: Sommet, Julie, et al.
Publicado: (2021) -
Neuropathic Pain in Children with Sickle Cell Disease: The Hidden Side of the Vaso-Occlusive Crisis
por: Sigalla, Jeanne, et al.
Publicado: (2021) -
Early splenectomy in a large cohort of children with sickle cell anemia: risks and consequences
por: Mechraoui, Aimen, et al.
Publicado: (2023) -
Nitrous Oxide, or “Laughing Gas,” as an Anæsthetic
por: Andrews, E.
Publicado: (1864)